These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32242539)

  • 1. Evolution of Italian laws banning trafficking, use and abuse of psychotropic drugs.
    Di Luca NM; Busardò FP; Pirani F; Varì MR
    Ann Ist Super Sanita; 2020; 56(1):76-89. PubMed ID: 32242539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Clinical Toxicology Perspective on the Therapeutic Use of Cannabis and Cannabinoids].
    Dinis-Oliveira RJ
    Acta Med Port; 2019 Feb; 32(2):87-90. PubMed ID: 30896388
    [No Abstract]   [Full Text] [Related]  

  • 3. Scheduling of new psychoactive substance the Swiss way: A review and critical analysis.
    Grafinger KE; Bernhard W; Weinmann W
    Sci Justice; 2019 Jul; 59(4):459-466. PubMed ID: 31256819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMPLEMENTATION OF DRUG ADDICTS RIGHT TO HEALTH PROTECTION (SEPARATE ASPECTS).
    Shevchuk O; Rzhevska O; Korop O; Pyliuha L
    Georgian Med News; 2018 Mar; (276):166-172. PubMed ID: 29697401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of drugs of abuse found in forensic testing of illicit drug seizures and urine samples from offenders/probationers in Hong Kong: A 3-year update.
    Cheng WC; Dao KL
    Forensic Sci Int; 2020 Dec; 317():110535. PubMed ID: 33075647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do international model drug control laws provide for drug availability?
    University of Wisconsin Pain & Policy Studies Group
    J Pain Palliat Care Pharmacother; 2009; 23(2):145-52. PubMed ID: 19492215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designer drugs: a medicinal chemistry perspective (II).
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2021 Apr; 1489(1):48-77. PubMed ID: 32396701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legislation targeting head shops selling new psychoactive substances and changes in drug-related psychiatric admissions: A national database study.
    Smyth BP; Daly A; Elmusharaf K; McDonald C; Clarke M; Craig S; Cullen W
    Early Interv Psychiatry; 2020 Feb; 14(1):53-60. PubMed ID: 30945460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
    Costa E Silva JA
    Hum Psychopharmacol; 2004 Jun; 19(4):215-24. PubMed ID: 15181649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 17983559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicines submitted to narcotics regulations in France, 1992-2007.
    Baumevieille M; Daveluy A; Maurain C; Bégaud B; Haramburu F
    Fundam Clin Pharmacol; 2009 Jun; 23(3):345-9. PubMed ID: 19453761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug policy and Collective Health: necessary dialogues.
    Gomes-Medeiros D; Faria PH; Campos GWS; Tófoli LF
    Cad Saude Publica; 2019 Jul; 35(7):e00242618. PubMed ID: 31365702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of current trends in the abuse of psychotropic substances and plants in Japan.
    Kikura-Hanajiri R; Uchiyama N; Goda Y
    Leg Med (Tokyo); 2011 May; 13(3):109-15. PubMed ID: 21377397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New psychoactive substances: An actual problem or an overestimated phenomenon?
    Vaiano F; Pascali JP; Bertol E
    Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate.
    Corazza O; Demetrovics Z; van den Brink W; Schifano F
    Int J Drug Policy; 2013 Jan; 24(1):82-3. PubMed ID: 22883544
    [No Abstract]   [Full Text] [Related]  

  • 16. [Abuse of prescribed sleeping, narcotic or psychotropic agents].
    Boxho P
    Rev Med Liege; 1999 Oct; 54(10):814-8. PubMed ID: 10605317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health issue brief: medical marijuana: year end report-2004.
    Varma P
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15765574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEA reschedules hydrocodone combination products.
    Pergolizzi JV
    Pain Pract; 2015 Feb; 15(2):95-7. PubMed ID: 25639283
    [No Abstract]   [Full Text] [Related]  

  • 19. [The actual Russian legislation in sphere of turn-over of drug agents and psychotropic substances].
    Abramov AY; Kosolapova NV; Mikhaiylova YV
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2014; (2):9-14. PubMed ID: 24960990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug dependence in therapy of chronic pain].
    Willweber-Strumpf A; Zenz M; Strumpf M
    Z Gesamte Inn Med; 1992 Jul; 47(7):312-7. PubMed ID: 1353931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.